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10.00 Atherosclerosis and melatonin. 
Dr A. Stacchiotti, Brescia, Italy. 
10.20 Aging: benefical melatonin effects. 
Dr G. Favero, Brescia, Italy. 
10.40 Melatonin in red wine keeps the cardiologist away. 
Prof. S. Lecour, Cape Town, South Africa. 
11.00 Selective melatonin receptor ligands for therapeutical applications. 
Prof M. Mor, Parma, Italy 
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11.40 Anti proliferative effect of melatonin in a human prostate cancer “in vivo” model: comparison of different formulations and delivery systems. 
Dr R. Paroni, Milan, Italy. 
12.00 Melatonin in traditional mediterranean foods, a new element to further comprehend the healthy potential of an ancient dietary style. 
Dr M. Iriti, Milan, Italy. 
12.20 Oral melatonin decreases need for sedatives and analgesics in critically ill patients. 
Dr G. Mistraletti, Milan, Italy. 
 
12.40 New therapeutic perspectives: open discussion 
 




9.00 Opening remarks 
9.15 Lecture: “Melatonin and its isomers as antioxidants: clinical relevance” 
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